Sanguine BIO conjunctival swab matrix prospective collection

Ended Purchase Order Awarded

Contract number
75D30124P19767
Awardee
Awarding agency
Obligated
$77,705

Award facts

Opportunity
  • 75D30124Q78139 Solicitation number
Contract value 100% obligated
$77,705.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
621511 Medical Laboratories
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Van Nuys, CA 91403, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $77,705.00 firm fixed price purchase order contract to Sanguine Biosciences, Inc. for the SANGUINE BIO CONJUNCTIVAL SWAB MATRIX PROSPECTIVE COLLECTION project. The contract has a completion date of December 20, 2024 and does not have a set-aside designation. Sanguine Biosciences, Inc. is a for-profit organization based in Van Nuys, California. This award appears to be related to the CDC's public health research and data collection programs, though the specific details of the project are not provided.

Quick answers

Who was awarded contract 75D30124P19767?

75D30124P19767 was awarded to Sanguine Biosciences, Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on August 20, 2024.

How much is contract 75D30124P19767 worth?

The government has obligated $77,705 on 75D30124P19767.

Was contract 75D30124P19767 competed?

The extent of competition for 75D30124P19767 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award